Style | Citing Format |
---|---|
MLA | Hashemi M, et al.. "Does Adjunctive Prophylactic Intracoronary Infusion of Low Dose Alteplase Prevent No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention?." ARYA Atherosclerosis, vol. 19, no. 6, 2023, pp. 36-43. |
APA | Hashemi M, Ostovan J, Sadeghi M, Shirvani E, Safaei A, Sanaei S (2023). Does Adjunctive Prophylactic Intracoronary Infusion of Low Dose Alteplase Prevent No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention?. ARYA Atherosclerosis, 19(6), 36-43. |
Chicago | Hashemi M, Ostovan J, Sadeghi M, Shirvani E, Safaei A, Sanaei S. "Does Adjunctive Prophylactic Intracoronary Infusion of Low Dose Alteplase Prevent No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention?." ARYA Atherosclerosis 19, no. 6 (2023): 36-43. |
Harvard | Hashemi M et al. (2023) 'Does Adjunctive Prophylactic Intracoronary Infusion of Low Dose Alteplase Prevent No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention?', ARYA Atherosclerosis, 19(6), pp. 36-43. |
Vancouver | Hashemi M, Ostovan J, Sadeghi M, Shirvani E, Safaei A, Sanaei S. Does Adjunctive Prophylactic Intracoronary Infusion of Low Dose Alteplase Prevent No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention?. ARYA Atherosclerosis. 2023;19(6):36-43. |
BibTex | @article{ author = {Hashemi M and Ostovan J and Sadeghi M and Shirvani E and Safaei A and Sanaei S}, title = {Does Adjunctive Prophylactic Intracoronary Infusion of Low Dose Alteplase Prevent No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention?}, journal = {ARYA Atherosclerosis}, volume = {19}, number = {6}, pages = {36-43}, year = {2023} } |
RIS | TY - JOUR AU - Hashemi M AU - Ostovan J AU - Sadeghi M AU - Shirvani E AU - Safaei A AU - Sanaei S TI - Does Adjunctive Prophylactic Intracoronary Infusion of Low Dose Alteplase Prevent No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention? JO - ARYA Atherosclerosis VL - 19 IS - 6 SP - 36 EP - 43 PY - 2023 ER - |